Back to all available

Research on the pathological features of BRCA-mutated breast cancer in Shenzhen, China: A single-center study

genomics
oncology
pathology
surgery-and-surgical-specialties

Abstract

Objective: To analyze and compare the pathological characteristics of BRCA-mutated and non-BRCA-mutated breast cancer patients at Shenzhen People's Hospital.

Methods: A retrospective analysis of 409 breast cancer patients (2016–2024) meeting inclusion criteria was conducted using next-generation sequencing for genetic testing and SPSS for statistical analysis.

Results: 1. In the BRCA group, 35 cases (68.6%) had tumor sizes ≤2 cm; 18 cases (35.3%) had positive axillary lymph nodes; 48 cases (94.1%) were invasive carcinoma; and 29 cases (56.9%) were histological grade III. 2. In molecular subtyping, the BRCA1 group had 20 cases (74.1%) of triple-negative type, whereas the BRCA2 group had 8 cases (36.4%) of Luminal A and 11 cases (50.0%) of Luminal B.

Conclusions: This population-based study found that among breast cancer patients in Shenzhen, China, tumors with BRCA gene mutations were predominantly invasive carcinomas, frequently associated with axillary lymph node metastasis and grade III histological characteristics, compared to sporadic breast cancers. BRCA1-mutated breast cancers showed a statistically significant tendency toward the triple-negative molecular subtype. This statistically significant finding aligns with international research. International studies indicate that BRCA2-associated breast cancers often exhibit Luminal-type characteristics. However, because all study participants were of Chinese ethnicity, the results showed that BRCA2-associated breast cancers in the Chinese population in Shenzhen showed no significant predisposition to Luminal-type molecular features compared to sporadic breast cancer patients.

Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.
  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].